Bullet Biotechnology using the cancer vaccine approach to target B cell lymphomas
Bay Area cancer vaccine maker Bullet Biotechnology is developing a therapy for B cell lymphomas, hacking a patient’s own immune system to treat these cancers. It takes the typical vaccine approach – targeting a marker exclusive to B cells that elicits a cellular immune response – from both T and B cells. Bullet uses directed conjugation to attach a […]